|
KMID : 1191520210260010039
|
|
Journal of Korean Traditional Oncology
2021 Volume.26 No. 1 p.39 ~ p.48
|
|
|
A Case Report of Pancreatic Cancer with Liver Metastasis Patient Treated with Integrative Cancer Treatment
|
|
Ko Eun-Ju
Myong Ji-Soo
Kim Jong-Hee
Park Ji-Hye
Park So-Jung
Lee Yeon-Weol
Yoo Hwa-Seung
|
|
|
Abstract
|
|
|
Objective: The purpose of this study is to report effects and potential of Integrative Cancer Treatment (ICT) on metastatic pancreatic cancer patient.
Methods: A 79-year-old pancreatic cancer patient diagnosed with metastasis on liver visited the Daejeon Korean medicine hospital of Daejeon university East West Cancer Center (EWCC) on May 2021. The patient has been received chemotherapy (gemcitabine plus abraxane) and concurrently treated with ICT since May 2021. The clinical outcomes were measured by computed tomography, laboratory findings including tumor markers (CEA, CA19-9) and numeric rating scales (NRS). Laboratory analysis and National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE), version 5.0 were used to evaluate the safety of ICT.
Results: After treatment, constipation was relieved from NRS 5-6 to 2, both leg numbness was improved from NRS 9 to 2. Tumor size was generally decreased accompanying by reducing the levels of tumor markers. There were no severe adverse events induced by ICT based on NCI CTCAE version 5.0.
Conclusion: This case study suggests that ICT in combination with chemotherapy may help in the treatment of patients with metastatic pancreatic cancer.
|
|
|
KEYWORD
|
|
|
Pancreatic cancer, Liver metastasis, Gemcitabine, Abraxane, Integrative Cancer Treatment
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|